A-Labs Capital IV Corp. Announces Closing of Initial Public Offering
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWS WIRES/
CALGARY, Sept. 30, 2019 /CNW/ - A-LABS CAPITAL IV CORP. (the "Corporation"), a capital pool company, is pleased to announce that it has submitted all materials for final listing approval for its common shares to the TSX Venture Exchange (the "Exchange"), and on September 30, 2019 closed its initial public offering of 2,000,000 common shares at $0.10 per share for aggregate gross proceeds of $200,000 through Haywood Securities Inc., which acted as agent for the Corporation (the "Offering"). The Corporation expects that trading will commence on, or about, October 2, 2019, under the symbol "ALCC.P".
Upon closing of the Offering, the Corporation granted 400,000 incentive stock options to its directors and officers which options are exercisable within five years from the date of grant at an exercise price of $0.10 per share. In addition, the Corporation granted an aggregate of 200,000 options to Haywood Securities Inc. (and sub agents), which options are exercisable until 24 months after the date of listing of the common shares of the Corporation on the Exchange at an exercise price of $0.10 per share. Following completion of the Offering, the Corporation now has 4,000,000 common shares issued and outstanding (2,000,000 of which are subject to escrow restrictions).
The only business of the Corporation is the identification and evaluation of assets or businesses with a view to completing a "Qualifying Transaction" as defined by the policies of the Exchange. The funds raised under the Offering will be used to pursue such Qualifying Transaction. Under the Exchange's policies, the Corporation has 24 months to identify and close a Qualifying Transaction. Investors are cautioned that trading in the securities of a capital pool company should be considered highly speculative.
THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE A-Labs Capital IV Corp.
contact Shay Benhamou, CEO and Director of the Corporation at: Electronic mail: [email protected]
Share this article